Skip to main content

Peer Review reports

From: Low-dose axitinib rechallenge with positive outcomes in a patient with metastatic renal cell carcinoma refractory to interferon α, sunitinib, axitinib, and nivolumab therapies: a case report

Original Submission
10 Jan 2019 Submitted Original manuscript
13 Jan 2019 Reviewed Reviewer Report - Ozge Keskin
29 Jan 2019 Reviewed Reviewer Report - aisha alosail
30 Jan 2019 Reviewed Reviewer Report - Vineet Kwatra
3 Feb 2019 Author responded Author comments - Masaki Murata
Resubmission - Version 2
3 Feb 2019 Submitted Manuscript version 2
21 Feb 2019 Author responded Author comments - Masaki Murata
Resubmission - Version 3
21 Feb 2019 Submitted Manuscript version 3
3 Mar 2019 Author responded Author comments - Masaki Murata
Resubmission - Version 4
3 Mar 2019 Submitted Manuscript version 4
Publishing
5 Mar 2019 Editorially accepted
22 Apr 2019 Article published 10.1186/s13256-019-2041-8

You can find further information about peer review here.

Back to article page